Beatrice Hecker, MD
Obstetrics & Gynecology · Miami, FLNPI 1770506156
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Millicent US Inc at 24.6% of the total. Reporting peaked in 2020 at $96 and has fallen 75.8% since, to $23 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in FL, where the typical reported total is $820.
Across 16 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Millicent US Inc$77
- Exeltis, USA Inc.$67
- AbbVie$48
- Therapeuticsmd, Inc.$35
- Ascend Therapeutics US, LLC$24
- Evofem Biosciences, Inc.$23
- plus $39 from 2 others
Across 26 payments — averaging $6592.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$81K
- Mitsubishi Tanabe Pharma Development America, Inc.$66K
- Ferring International Pharmascience Center US$13K
- Bayer$11K
What the payments were for
- Food & beverage$28892%
- Gifts$248%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Millicent US Inc | 4 | $77 |
| Exeltis, USA Inc. | 3 | $67 |
| AbbVie | 2 | $48 |
| Therapeuticsmd, Inc. | 2 | $35 |
| Ascend Therapeutics US, LLC | 2 | $24 |
| Evofem Biosciences, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
How this compares
$312 in reported general payments places this provider in the 30th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 170 | $4,949 |
| PremarinEstrogens, Conjugated | 14 | $4,342 |
| Clindamycin Phosphate | 41 | $2,179 |
| Metronidazole | 19 | $754 |
| Mometasone Furoate | 73 | $694 |
| Estradiol (Twice Weekly)Estradiol | 11 | $631 |
| Halobetasol Propionate | 21 | $543 |
| Terconazole | 12 | $260 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 33 | $219 |
| Alendronate Sodium | 15 | $76 |
| Mupirocin | 15 | $53 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Miami
- Youssef MouhayarMiami$162K
- Rebeca MartinezMiami$108K
- Jason JamesMiami$97K
- Peter KhamvongsaMiami$67K
- Abdulrahman SinnoMiami$67K
- Ingrid ParedesMiami$65K
- Karen Salazar ValdesMiami$29K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.